Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Zappa

Showing results (71-80 of 211) with videos related to

Pageof 22
Sort By:
Clinical Chemistry and Laboratory Medicine|February 7, 2014
An epidemiology-based model to estimate the rate of inappropriateness of tumor marker requestsMassimo Gion, Roberta Franceschini, Claudia Rosin, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2005
Determining overdiagnosis by screening with DRE/TRUS or PSA (Florence pilot studies, 1991-1994)Stefano Ciatto, Ginetta Gervasi, Rita Bonardi, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|November 16, 2016
Does low-dose aspirin use for cardiovascular disease prevention reduce colorectal cancer deaths? A comparison of two cohorts in the Florence district, ItalyLeonardo Ventura, Guido Miccinesi, Alessandro Barchielli, et al.
Journal of Medical Screening|January 25, 2011
Is human papillomavirus screening preferable to current policies in vaccinated and unvaccinated women? A cost-effectiveness analysisGabriele Accetta, Annibale Biggeri, Giulia Carreras, et al.
International Journal of Cancer|December 27, 2018
Impact of screening programme using the faecal immunochemical test on stage of colorectal cancer: Results from the IMPATTO studyMassimo Vicentini, Manuel Zorzi, Emanuela Bovo, et al.
Breast Cancer Research : BCR|August 11, 2018
Volumetric breast density and risk of advanced cancers after a negative screening episode: a cohort studyDonella Puliti, Marco Zappa, Paolo Giorgi Rossi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 21, 2005
Incidence trends of adenocarcinoma of the cervix in 13 European countriesFreddie Bray, Bendix Carstensen, Henrik Møller, et al.
La Radiologia Medica|September 3, 2003
Comparison of standard reading and computer aided diagnosis (CAD) on a proficiency test of screening mammographyStefano Ciatto, Beniamino Brancato, Marco Rosselli Del Turco, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 10, 2013
The impact of immunochemical faecal occult blood testing on colorectal cancer incidenceLeonardo Ventura, Paola Mantellini, Grazia Grazzini, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|July 19, 2016
Faecal immunochemical test in subjects not attending screening computed tomography colonography and colonoscopy in a randomized trialLapo Sali, Leonardo Ventura, Mario Mascalchi, et al.
Pageof 22

Showing results (71-80 of 211) with videos related to

Sort By:
Pageof 22
Clinical Chemistry and Laboratory Medicine|February 7, 2014
An epidemiology-based model to estimate the rate of inappropriateness of tumor marker requestsMassimo Gion, Roberta Franceschini, Claudia Rosin, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2005
Determining overdiagnosis by screening with DRE/TRUS or PSA (Florence pilot studies, 1991-1994)Stefano Ciatto, Ginetta Gervasi, Rita Bonardi, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|November 16, 2016
Does low-dose aspirin use for cardiovascular disease prevention reduce colorectal cancer deaths? A comparison of two cohorts in the Florence district, ItalyLeonardo Ventura, Guido Miccinesi, Alessandro Barchielli, et al.
Journal of Medical Screening|January 25, 2011
Is human papillomavirus screening preferable to current policies in vaccinated and unvaccinated women? A cost-effectiveness analysisGabriele Accetta, Annibale Biggeri, Giulia Carreras, et al.
International Journal of Cancer|December 27, 2018
Impact of screening programme using the faecal immunochemical test on stage of colorectal cancer: Results from the IMPATTO studyMassimo Vicentini, Manuel Zorzi, Emanuela Bovo, et al.
Breast Cancer Research : BCR|August 11, 2018
Volumetric breast density and risk of advanced cancers after a negative screening episode: a cohort studyDonella Puliti, Marco Zappa, Paolo Giorgi Rossi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 21, 2005
Incidence trends of adenocarcinoma of the cervix in 13 European countriesFreddie Bray, Bendix Carstensen, Henrik Møller, et al.
La Radiologia Medica|September 3, 2003
Comparison of standard reading and computer aided diagnosis (CAD) on a proficiency test of screening mammographyStefano Ciatto, Beniamino Brancato, Marco Rosselli Del Turco, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 10, 2013
The impact of immunochemical faecal occult blood testing on colorectal cancer incidenceLeonardo Ventura, Paola Mantellini, Grazia Grazzini, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|July 19, 2016
Faecal immunochemical test in subjects not attending screening computed tomography colonography and colonoscopy in a randomized trialLapo Sali, Leonardo Ventura, Mario Mascalchi, et al.
Pageof 22